Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.37 |
| ▸ | FGB | P02675 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | DRD2 | P14416 | 2/20 | 0.32 |
| ▸ | HTR6 | P50406 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13681627 | 0.84 | L3MBTL1 (0.36) | TP53L3MBTL1POLBTDP1NOTUM | |
| SCHEMBL27433483 | 0.77 | TP53 (0.38) | TP53L3MBTL1FGBPOLBNOTUM | |
| SCHEMBL31726005 | 0.76 | HTR6 (0.35) | TP53L3MBTL1FGBPOLBTDP1 | |
| SCHEMBL16803621 | 0.73 | L3MBTL1 (0.39) | TP53L3MBTL1FGBPOLBTDP1 | |
| SCHEMBL27433462 | 0.73 | PDE3B (0.43) | TDP1 | |
| SCHEMBL21245682 | 0.71 | CSF1R (0.37) | PKMHTR6KMT2A | |
| SCHEMBL23729551 | 0.69 | L3MBTL1 (0.37) | TP53L3MBTL1FGBPOLBTDP1 | |
| SCHEMBL18652293 | 0.68 | PKM (0.38) | TP53L3MBTL1FGBPOLBTDP1 | |
| SCHEMBL30954119 | 0.68 | NOTUM (0.38) | TP53L3MBTL1POLBNOTUMPKM | |
| SCHEMBL27432668 | 0.68 | NOTUM (0.38) | TP53L3MBTL1POLBNOTUMPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4630412-A1 | COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS | NMD Pharma A/S (DK) | 2025-10-15 | — | — | EP | disclosed |
| WO-2024121130-A1 | COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS | NMD PHARMA A/S (DK) | 2024-06-13 | — | — | WO | disclosed |
| WO-2024121130-A1 | COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS | NMD PHARMA A/S (DK) | 2024-06-13 | — | — | WO | disclosed |